Cellosaurus HT-29 BR300 (CVCL_DH90)
| Cell line name | HT-29 BR300 |
|---|---|
| Synonyms | HT29 BR300; BR300 |
| Accession | CVCL_DH90 |
| Resource Identification Initiative | To cite this cell line use: HT-29 BR300 (RRID:CVCL_DH90) |
| Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade). Derived from site: In situ; Colon; UBERON=UBERON_0001155. |
| Sequence variations |
|
| Disease | Colon adenocarcinoma (NCIt: C4349) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0320 (HT-29) |
| Sex of cell | Female |
| Age at sampling | 44Y |
| Category | Cancer cell line |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_DH90 |
| Encyclopedic resources | Wikidata; Q54896511 |
| Gene expression databases | GEO; GSM736970 |
| Polymorphism and mutation databases | Progenetix; CVCL_DH90 |
| Entry history | |
| Entry creation | 13-Jul-2016 |
| Last entry update | 19-Dec-2024 |
| Version number | 18 |